1. Home
  2. ADIL vs DFLI Comparison

ADIL vs DFLI Comparison

Compare ADIL & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • DFLI
  • Stock Information
  • Founded
  • ADIL 2010
  • DFLI 2020
  • Country
  • ADIL United States
  • DFLI United States
  • Employees
  • ADIL N/A
  • DFLI N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • ADIL Health Care
  • DFLI Technology
  • Exchange
  • ADIL Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • ADIL 4.3M
  • DFLI 5.0M
  • IPO Year
  • ADIL 2018
  • DFLI N/A
  • Fundamental
  • Price
  • ADIL $0.69
  • DFLI $0.54
  • Analyst Decision
  • ADIL Strong Buy
  • DFLI Strong Buy
  • Analyst Count
  • ADIL 1
  • DFLI 4
  • Target Price
  • ADIL $8.00
  • DFLI $12.83
  • AVG Volume (30 Days)
  • ADIL 47.3K
  • DFLI 265.0K
  • Earning Date
  • ADIL 05-13-2025
  • DFLI 05-13-2025
  • Dividend Yield
  • ADIL N/A
  • DFLI N/A
  • EPS Growth
  • ADIL N/A
  • DFLI N/A
  • EPS
  • ADIL N/A
  • DFLI N/A
  • Revenue
  • ADIL N/A
  • DFLI $50,645,000.00
  • Revenue This Year
  • ADIL N/A
  • DFLI $42.48
  • Revenue Next Year
  • ADIL N/A
  • DFLI $42.95
  • P/E Ratio
  • ADIL N/A
  • DFLI N/A
  • Revenue Growth
  • ADIL N/A
  • DFLI N/A
  • 52 Week Low
  • ADIL $0.58
  • DFLI $0.46
  • 52 Week High
  • ADIL $3.00
  • DFLI $13.14
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 46.74
  • DFLI 24.41
  • Support Level
  • ADIL $0.65
  • DFLI $0.46
  • Resistance Level
  • ADIL $0.74
  • DFLI $0.67
  • Average True Range (ATR)
  • ADIL 0.07
  • DFLI 0.09
  • MACD
  • ADIL 0.00
  • DFLI 0.02
  • Stochastic Oscillator
  • ADIL 47.73
  • DFLI 16.10

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: